Insider Sell: 10x Genomics
9:27AM ET 11/30/2021 MT NewswiresSridhar Kosaraju, Director, on November 24, 2021, sold 1,500 shares in 10x Genomics (TXG) for $225,084. Following the Form 4 filing with the SEC, Kosaraju...
Quotes Snapshot > TXG
10X Genomics Inc TXG:NASDAQ
Last Price$145.94Cboe Real-Time Last Sale as of 1:33PM ET 12/01/21
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-6.87(4.50%)
Bid (Size)$145.70 (105)
Ask (Size)$145.99 (126)
Day Low / High$145.72 - 157.74
Volume393.8 K
Read more news Recent News
Insider Sell: 10x Genomics
6:33AM ET 11/17/2021 MT NewswiresBradford Crutchfield, Chief Commercial Officer, on November 12, 2021, sold 17,000 shares in 10x Genomics (TXG) for $2,803,557. Following the Form 4 filing...
Insider Sell: 10x Genomics
11:56AM ET 11/05/2021 MT NewswiresSerge Saxonov, Director, Chief Executive Officer, on November 02, 2021, sold 15,000 shares in 10x Genomics (TXG) for $2,418,687. Following the Form 4...
Sector Update: Health Care Stocks Struggle Throughout Thursday Session
4:04PM ET 11/04/2021 MT NewswiresHealth care stocks finished near their intra-day lows, with the NYSE Health Care Index falling 0.8%, while the SPDR Health Care Select Sector ETF (XLV)...
View all Commentary and Analysis
The Synthetic Biology Revolution: Investing In The Science Of Sustainability
10:30AM ET 11/25/2021 Seeking AlphaClearBridge Aggressive Growth Strategy Portfolio Manager Commentary Q3 2021
1:14PM ET 10/18/2021 Seeking AlphaBIGZ: A Long-Term Income Investment With Some Growth Opportunity
5:23AM ET 8/31/2021 Seeking AlphaTop Buys From The Best Money Managers (Q2 2021)
1:59PM ET 8/20/2021 Seeking AlphaCompany Profile
Business Description
| Number of Employees | N/A |
| Recent SEC Filing | 11/29/2021 4 |
Company Highlights
| Price Open | $156.00 |
| Previous Close | $152.81 |
| 52 Week Range | $128.15 - 208.99 |
| Market Capitalization | $13.4 B |
| Shares Outstanding | 91.6 M |
| Sector | Health Technology |
| Industry | Biotechnology | Next Earnings Announcement | 02/16/2022 |
Options Summary
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
View all fundamentalsFundamentals
| Price / Earnings | N/A |
| Earnings per Share | -$1.58 |
| Beta vs. S&P 500 | N/A |
| Revenue | N/A |
| Net Profit Margin | -99.17% |
| Return on Equity | -59.21% |
Analyst Ratings as of 11/08/2021
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |